FDA Adverse Event Other Summary report: N

9613347-2009-00006

MDR report key: 1344846 · Received March 11, 2009

Report

Report Number
9613347-2009-00006
Event Type
Other
Date Received
March 11, 2009
Product Code
LQR
Report Source
Manufacturer report

Narratives

Additional Manufacturer Narrative · 1

HEMATOMA IS A KNOWN SIDE EFFECT OF LITHOTRIPSY TREATMENT AND IS ADDRESSED IN OUR LABELING. UNIT WAS INSTALLED IN 2009; COMPLETE INSTALLATION TESTING WAS DONE AT THE TIME; ADDITIONALLY CSA TESTING WAS DONE FIVE DAYS LATER; UNIT PASSED ALL TESTS. NO MALFUNCTION WAS NOTED AT THAT TIME OF THE PROCEDURE. UNIT HAS BEEN IN CONTINUOUS SERVICE SINCE THE EVENT. THE HOSP HAS TREATED APPROX 120-130 PTS WITH NO PROBLEMS REPORTED. THERE IS NO PLAN TO SCHEDULE EVAL OF UNIT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LQR

Patients

Seq Age Sex Outcome Treatment
1